Published in:
Open Access
01-02-2011 | Poster presentation
AZD9773 is a novel and potent anti-TNFα polyclonal ovine immune Fab
Authors:
P Newham, P Ceuppens, G Davies, J Growcott
Published in:
Critical Care
|
Special Issue 1/2011
Login to get access
Excerpt
The release of cytokines into the circulation is an essential part of the inflammatory cascade that underlies sepsis. Experimental and clinical data have shown that the proinflammatory cytokine TNFα is a principal mediator of this cascade [
1‐
3]. The investigational drug AZD9773, intended for intravenous infusion, contains ovine immune fragments (Fabs) of IgG that bind to human (hu)-TNFα. Here we describe the
in vitro and
in vivo pharmacology of AZD9773. …